Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesOpen-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease
Amyotrophic Lateral Sclerosis, 08/28/09
Bedlack RS et al. – The results justify a placebo–controlled study of levetiracetam for treatment of cramps and spasticity in patients with motor neuron diseases, and suggest that this can be accomplished with a small number of subjects followed for a short time.
Related Articles
Pancytopenia Associated with Levetiracetam Treatment
Clinical Drug Investigation, 10/15/09
Relevance Score: 88%
Utility of levetiracetam in patients with subarachnoid hemorrhage
Seizure - European Journal of Epilepsy, 10/30/09
Relevance Score: 84%
Experience with Intravenous Levetiracetam in Status Epilepticus: A Retrospective Case Series
CNS Drugs, 10/29/09
Relevance Score: 83%
Sequential intrarectal diazepam and intravenous levetiracetam in treating acute repetitive and prolonged seizures
Epilepsia, 10/29/09
Relevance Score: 82%
The need for broad spectrum and safe anti-epileptic drugs in childhood epilepsy
Acta Neurologica Belgica, 10/20/09
Relevance Score: 80%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09
Health related quality of life in early Parkinson's disease: Impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort
Parkinsonism & Related Disorders, 12/04/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/04/09
Today in Neuropathy/Myopathy...keeping you current
Receive free subspecialty "5-minute updates" via email
Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma
Cancer Science, 12/04/09
Calciphylaxis as a Catastrophic Complication in a Patient with POEMS Syndrome
Case Reports in Neurology, 12/04/09
A survey of treatment practices in diabetic peripheral neuropathy
Primary Care Diabetes, 12/03/09
Sponsor
Article Search
Sponsor